Patient characteristics: induction chemotherapy (N = 348)
. | DA, n = 116 . | IA, n = 118 . | MA, n = 114 . |
|---|---|---|---|
| Sex, no. | |||
| Male | 65 | 63 | 65 |
| Female | 50 | 55 | 49 |
| Performance status, no. | |||
| 0-1 | 94 | 98 | 95 |
| 2-4 | 19 | 20 | 17 |
| Age | |||
| Median (range), y | 67 (56-82) | 67.5 (56-86) | 69 (56-84) |
| 56 y-60 y, n | 20 | 20 | 18 |
| 61 y-65 y, n | 29 | 30 | 14 |
| 66 y-70 y, n | 26 | 31 | 40 |
| 71 y-75 y, n | 24 | 24 | 25 |
| 76+ y, n | 17 | 13 | 17 |
| WBC count × 109/L, median (range) | 112.5 (7-12.88) | 65.5 (.6-2000) | 72 (6-2070) |
| Platelet count × 109/L, median (range) | 52 (6-346) | 61 (7-351) | 51 (2-261) |
. | DA, n = 116 . | IA, n = 118 . | MA, n = 114 . |
|---|---|---|---|
| Sex, no. | |||
| Male | 65 | 63 | 65 |
| Female | 50 | 55 | 49 |
| Performance status, no. | |||
| 0-1 | 94 | 98 | 95 |
| 2-4 | 19 | 20 | 17 |
| Age | |||
| Median (range), y | 67 (56-82) | 67.5 (56-86) | 69 (56-84) |
| 56 y-60 y, n | 20 | 20 | 18 |
| 61 y-65 y, n | 29 | 30 | 14 |
| 66 y-70 y, n | 26 | 31 | 40 |
| 71 y-75 y, n | 24 | 24 | 25 |
| 76+ y, n | 17 | 13 | 17 |
| WBC count × 109/L, median (range) | 112.5 (7-12.88) | 65.5 (.6-2000) | 72 (6-2070) |
| Platelet count × 109/L, median (range) | 52 (6-346) | 61 (7-351) | 51 (2-261) |
WBC indicates white blood cell.